Return to Main Page SOH approves the HTAC recommendation on tocilizumab for COVID-19 in the Philippine National Formulary (PNF) The Secretary of Health (SOH) approved the HTAC recommendation on the addition of tocilizumab for COVID-19 in the Philippine National Formulary (PNF) on 11 May 2022. On 15 March 2022, the Philippine FDA issued the CPR of tocilizumab continue reading : SOH Decision: Tocilizumab for the Treatment of COVID-19